The Philippines Has Approved ReCOV For Phase II/III Cinical Trial

/PRNewswire/ -- The Philippines has approved Recombinant Two-Component COVID-19 Vaccine (ReCOV) developed by Jiangsu Recbio Technology Co., Ltd. ("Recbio") for...

Related Keywords

China ,Taizhou ,Jiangsu ,Philippines ,New Zealand ,Liu Yong ,Fengcai Zhu ,Jiangsu Medical Products Administration ,Taizhou Medical New Industrial Development Zone ,Jiangsu Recbio Technology Co Ltd ,Human Health ,International Phase ,Jiangsu Provincial Center ,Recombinant Two Component ,General Manager ,Pharmaceutical Production License ,Good Manufacturing Practices ,Disease Control ,Taizhou Medical New ,High Tech Industrial Development Zone ,Professor Fengcai Zhu ,Innovative Vaccine ,Jiangsu Recbio Technology Co ,Td ,